Biography:
Philip Sheridan holds a BSc In Physics and most recently earned an MSc in Pharmacovigilance from the University of Hertfordshire in 2021, with a thesis focusing on the impact of multiple reporting sources on signal detection scores for SSRIs & TNF inhibitors. He is the Principal Pharmacovigilance Solutions Consultant at Oracle Life Science leading the EMEA region, having previously held multiple pharmacovigilance roles in industry.
Title : An overview of the impact of real-world data on signal detection